Literature DB >> 7044325

The antimalarial activity of N-benzyl-oxydihydrotriazines. IV. The development of resistance to BRL 6231 (4,6-diamino-1,2-dihyydro-2-,2-dimethyl-1-(2,4,5-trichloropropyloxy)-1,3,5 triazine hydrochloride) by Plasmodium berghei.

D J Knight, P Williamson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7044325

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  4 in total

1.  Regioisomerization of Antimalarial Drug WR99210 Explains the Inactivity of a Commercial Stock.

Authors:  T Parks Remcho; Sravanthi D Guggilapu; Phillip Cruz; Glenn A Nardone; Gavin Heffernan; Robert D O'Connor; Carole A Bewley; Thomas E Wellems; Kristin D Lane
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

2.  In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.

Authors:  M D Edstein; S Bahr; B Kotecka; G D Shanks; K H Rieckmann
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

3.  Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist.

Authors:  W T Hughes; D P Jacobus; C Canfield; J Killmar
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

4.  In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.

Authors:  P A Winstanley; E K Mberu; I S Szwandt; A M Breckenridge; W M Watkins
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.